Minimizing polymorphic metabolism in drug discovery: evaluation of the utility of in vitro methods for predicting pharmacokinetic consequences associated with …
JP Gibbs, R Hyland, K Youdim - Drug metabolism and disposition, 2006 - ASPET
Minimizing interindividual variability in drug exposure is an important goal for drug
discovery. The reliability of the selective CYP2D6 inhibitor quinidine was evaluated in a …
discovery. The reliability of the selective CYP2D6 inhibitor quinidine was evaluated in a …
[引用][C] Minimizing polymorphic metabolism in drug discovery: evaluation of the utility of in vitro methods for predicting pharmacokinetic consequences associated with …
JP Gibbs, R Hyland, K Youdim - Drug Metabolism and Disposition, 2006 - ASPET
Minimizing inter-individual variability in drug exposure is an important goal for drug
discovery. The reliability of the selective CYP2D6 inhibitor quinidine was evaluated in a …
discovery. The reliability of the selective CYP2D6 inhibitor quinidine was evaluated in a …
Minimizing polymorphic metabolism in drug discovery: evaluation of the utility of in vitro methods for predicting pharmacokinetic consequences associated with …
JP Gibbs, R Hyland, K Youdim - Drug metabolism and …, 2006 - pubmed.ncbi.nlm.nih.gov
Minimizing interindividual variability in drug exposure is an important goal for drug
discovery. The reliability of the selective CYP2D6 inhibitor quinidine was evaluated in a …
discovery. The reliability of the selective CYP2D6 inhibitor quinidine was evaluated in a …
Minimizing polymorphic metabolism in drug discovery: evaluation of the utility of in vitro methods for predicting pharmacokinetic consequences associated with …
JP Gibbs, R Hyland, K Youdim - Drug Metabolism and Disposition …, 2006 - europepmc.org
Minimizing interindividual variability in drug exposure is an important goal for drug
discovery. The reliability of the selective CYP2D6 inhibitor quinidine was evaluated in a …
discovery. The reliability of the selective CYP2D6 inhibitor quinidine was evaluated in a …
[引用][C] Minimizing polymorphic metabolism in drug discovery: Evaluation of the utility of in vitro methods for predicting pharmacokinetic consequences associated with …
JP GIBBS, R HYLAND… - Drug metabolism and …, 2006 - pascal-francis.inist.fr
Minimizing polymorphic metabolism in drug discovery : Evaluation of the utility of in vitro
methods for predicting pharmacokinetic consequences associated with CYP2D6 metabolism …
methods for predicting pharmacokinetic consequences associated with CYP2D6 metabolism …